/VOL 3 No. 1 Full Issue – January 2001

VOL 3 No. 1 Full Issue – January 2001

$30.00 $20.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

In This Issue

Publisher’s Statement A League of One’s Own

Bipolar Affective Disorder: Does Psychosocial Treatment Add to the Efficacy of Drug Therapy? By David J. Miklowitz, PhD

Vol 3 Issue No. 1 Masthead

The Neurobiology of Bipolar Disorder, by Husseini K. Manji, MD

Expert Consensus Guidelines for the Medication Treatment of Bipolar Disorder: A New Treatment Tool, by David A. Kahn, MD

The TEN Interview: Kay Redfield Jamison, PhD

A Test for Bipolar Disorder: The Mood Disorder Questionnaire, by Robert M. A. Hirschfield, MD

STEP- BD—A Design for Evaluating Effectiveness of Treatment for Bipolar Disorder, by Stephen M . Gray , BA

Letter From The Editor: Bipolar Disorder, by Myrna M. Weissman, PhD

Cover Essay: The Color of Steady by Kay Redfield Jamison, PhD

Vol 3 Issue No. 1 Cost & Therapeutics

Kay Jamison and the Scientific Push to Understand and Treat Bipolar Disease